Sign In
Buy MEDIF
$0.0539
-0.0024 (-4.33%)
At Close: Jun 03, 2026
MediPharm Labs Sets Date to Report Third Quarter 2024 Financial Results
06:15am, Monday, 11'th Nov 2024
TORONTO , Nov. 11, 2024 /PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-ba
MediPharm Labs Announces Departure of President and Co-Founder Keith Strachan
07:35am, Thursday, 17'th Oct 2024
TORONTO , Oct. 17, 2024 /PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) ("MediPharm", "MediPharm Labs" or the "Company"), a specialized, research-driven company focused on pharmaceutic
MediPharm Labs Announces $2.1M Debt Repayment
06:45am, Tuesday, 17'th Sep 2024
Company Now Materially Debt Free with Over $13M in Cash TORONTO , Sept. 17, 2024 /PRNewswire/ - MediPharm Labs Corp. ("MediPharm" or the "Company") (TSX: LABS), a specialized, research-driven pharmac
MediPharm Labs Reports Second Quarter Results Closing in on Positive Adjusted EBITDA(1) as Gross Profit Continues to Improve
07:00am, Wednesday, 14'th Aug 2024
TORONTO , Aug. 14, 2024 /PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-bas
/R E P E A T -- MediPharm Labs Sets Date to Report Second Quarter 2024 Financial Results/
08:00am, Tuesday, 13'th Aug 2024
TORONTO , Aug. 8, 2024 /PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-bas
MediPharm Labs Sets Date to Report Second Quarter 2024 Financial Results
04:30pm, Thursday, 08'th Aug 2024
TORONTO , Aug. 8, 2024 /PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-bas
MediPharm Labs Announces Voting Results From the 2024 Annual Meeting of Shareholders
05:15pm, Wednesday, 26'th Jun 2024
TORONTO , June 26, 2024 /PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company"), a pharmaceutical company specialized in precision-ba
MediPharm Labs Acquires Advanced Medical Cannabis Delivery Method Technology from Remidose Aerosols
06:45am, Thursday, 20'th Jun 2024
MediPharm has licenced global manufacturing, distribution, and sales rights of the novel advanced medical cannabis technology from Remidose Aerosols. Products include metered dose inhalers and aeros
MediPharm Labs Reports First Quarter Results
06:15am, Wednesday, 15'th May 2024
Completes Major Steps Towards Profitability with Best Revenue and Adjusted EBITDA in Over Three Years TORONTO , May 15, 2024 /PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ)
MediPharm Labs Sets Date to Report First Quarter 2024 Financial Results
04:30pm, Wednesday, 08'th May 2024
TORONTO , May 8, 2024 /PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based
MediPharm Labs Corp. (MEDIF) Q4 2023 Earnings Call Transcript
03:20pm, Wednesday, 27'th Mar 2024
MediPharm Labs Corp. (MEDIF) Q4 2023 Earnings Call Transcript
MediPharm Labs Provides Conference Call Recording Details
10:54am, Wednesday, 27'th Mar 2024
TORONTO , March 27, 2024 /PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-ba
MediPharm Labs Reports Fourth Quarter and Full Year Results
06:30am, Wednesday, 27'th Mar 2024
Annual Revenue and Adjusted EBITDA Improve by 50% TORONTO, March 27, 2024 /PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a p
MediPharm Labs Provides Update on German Cannabis Legalization
06:30am, Monday, 25'th Mar 2024
German federal states have voted to decriminalize the personal cultivation and use of cannabis. The new legislation that takes effect April 1, 2024, also removes medical cannabis from the German narco
MediPharm Labs Sets Date to Report Full Year and Fourth Quarter 2023 Financial Results
06:30am, Friday, 22'nd Mar 2024
TORONTO, March 22, 2024 /PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-bas
